Endoluminal Suturing Devices Industry Driven by Global Minimally Invasive Surgery Revolution

Endoluminal suturing devices are utilized in a wide range of minimally invasive conducts on hollow organs that call for the usage of surgical methods like suturing and stapling. The increasing obesity occurrence in numerous emerging countries as well as obesity-associated health problems are projected to boost endoluminal suturing device sales.

Gastrointestinal deformities, gastroesophageal reflux disease, and Bariatric procedures are just a few of the applications for which the items are offered by the participants and producers globally.

The global endoluminal suturing devices market is experiencing growth and is projected to reach USD 258.1 million by 2030.

To learn more about this report: https://bit.ly/3I9DNM0

Bariatric Surgery

Gastric bypass and other weight-loss operation — this surgery is also called bariatric surgery —includes doing modifications to your digestive system to support you in losing weight. Bariatric operation is conducted when exercise and diet are able not able to help you in losing weight or when you have severe health issues due to heavyweight. Some methods bound you in how much you can eat. Other techniques work by decreasing the body's capability to absorb nutrients and few procedures do both.

Gastrointestinal Surgery

Gastrointestinal operation is a cure for illnesses of the parts of the body associated with digestion. This comprises the small intestine, stomach, esophagus (ee-sof-uh-gus), rectum, and large intestine. It also comprises the pancreas, liver, and gallbladder

The operation might be done to extract a noncancerous or cancerous development or spoiled part of the body, like the intestine. It may also be utilized to treat issues like a hernia. Minor surgical measures are used to screen and detect issues with the digestive system.

Smaller Incisions

While open operation sometimes needs major cuts that can be quite long, the endoscopic operation needs just one cut of a few centimeters in length. In some cases, general anesthesia is not essential for the procedure, just some local anesthetic and sedation is enough.

Ongoing Research & Development 

Clinicians and other healthcare experts are now innovating diverse procedures utilized for weight loss as well as GIT operations due to the newer interferences and technological advancements in endoluminal tools.

The surgery with their usage removes the requirement for open surgery as they are able to remove it without surgery; on top of that, they offer quicker healing, greater patient satisfaction, fewer hospital visits, and shorter hospital stays. These aforesaid benefits are gaining popularity for this market and showed to be highly profitable.

There has been a noteworthy growth in popularity in this field mainly because of the launch of robotic suturing systems. For the endoluminal method, the usage of robotic arms allows doctors to mimic manual human-like wrist movements, significantly decreasing mistakes. Also, this method provides doctors with robotic arm suppleness as well as three-dimensional vision. Consequently, the above-mentioned factors are fuelling the requirement for such devices and refining surgical results.

Hence, the increasing obesity occurrence in numerous emerging countries as well as obesity-associated health problems, are the major factors that will drive the endoluminal suturing devices industry in the future as well. 

Read More

Companion Animal Diagnostics Industry To be Dominated by North America

As per a report by P&S Intelligence, the total revenue generated by the companion animal diagnostics market was USD 2,424 million in 2022, and it will grow at a CAGR of 9.40% in the years to come, to reach USD 4,974 million by 2030.

To learn more about this report: https://bit.ly/42DfP3X

The dog category had the largest share in 2022. This is because of the snowballing population and acceptance rate of dogs and the increasing cases of zoonotic diseases, leading to the growing demand for veterinary visits and diagnostics for dogs. In 2023, the global population of dogs will be around 900 million out of which about 470 million are pet dogs. 

With this enormous and growing number, the necessity for diagnostics facilities for dogs will similarly rise, and therefore, this will straight-away impact the industry positively.

Cat is the second-largest in the animal type and the largest in Europe because of the larger count of pet cats than dogs in the region. For example, as per the FEDIAF, there are 113 million pet cats in Europe as opposed to 92 million pet dogs.

Clinical pathology held the largest share in the companion animal diagnostics market. This is because of the snowballing cases of chronic ailments in companion animals. 

Clinical pathology is one of the primary steps for detection of these diseases in pets. Consequently, because of the evolving and reemerging diseases in animals, the category leads the industry and it will continue doing the same in the years to come as well.

North America dominated the industry, with a revenue share or share of 41% in 2022, and it will have the fastest growth in the years to come. 

This is as a result of the rising population of companion animals, particularly in the U.S.; the pet insurance; and the rising health outlay on pets For example, as per APPA, in the U.S., about 70% of homes owned a pet, as of 2021.

Furthermore, APAC will also grow significantly in the years to come and provide prospects for players, because of the increasing prevalence of numerous zoonotic diseases, the growing consciousness about animal health, and the increasing income levels. 

Many initiatives are taken by governments of emerging countries for fighting ailment outbreaks in animals. Likewise, players growing in the region will observe lucrative gains and will reinforce their position in the market in the years to come.

Due to the increasing population of pet animals around the world, and the rising awareness in the people about the health of the pets, the demand for companion animal diagnostics will continue to increase in the near future.

Read More

North America Led the Anti-Biofilm Wound Dressing Market

As per a report by P&S Intelligence, the anti-biofilm wound dressing market generated a value of USD 730 million in 2022, and it will grow at an 8.9% CAGR, to touch USD 1,447 million, by 2030.

To learn more about this report: https://bit.ly/3pDT1SR

The growth in the industry is mainly attributed to the increasing consumption of alcohol & tobacco and sedentary & unhealthy lifestyles, which lead to the growing incidence of chronic diseases, therefore, increasing the incidence rate of chronic and acute lesions, along with the rising antimicrobial resistance threat, boosts the requirement for these products.

The chemical category accounted for the largest anti-biofilm wound dressing market revenue share, at approximately 46%, owing to the rising number of surgeries and increasing chronic wound incidence all over the world.

North America led the industry of anti-biofilm wound dressing, and it will maintain its position in the years to come, generating a value of USD 434 million, by the end of this decade. This is ascribed to the increasing incidence of sports injuries and the growing number of road accidents.

Additionally, the U.S. led the industry in North America, and it will advance at a rate of approximately 9%. This is credited to the strong infrastructure of healthcare and the existence of numerous major industry players. Furthermore, the presence of advantageous reimbursement policies will boost the industry's growth in the years to come.

Hence, with the increasing prevalence of chronic wounds and the mounting number of accidents, violence, and burns cases, the industry of anti-biofilm wound dressing will continue to grow significantly in the years to come.

Read More

SCADA Market Will Reach USD 16,994 Million by 2030

The total value of the global SCADA market was USD 9,600 million in 2022, and it will rise at a growth rate of above 7.4% shortly, reaching USD 16,994 million by 2030, according to P&S Intelligence. 

This growth can be credited to the high acceptance of Industry 4.0 solutions utilizing SCADA devices, the rising usage of software platforms including artificial intelligence and the Internet of Things, the growing requirement for industrial mobility solutions for better procedure management, and the growing advancements in wireless sensor networks (WSNs).

Artificial intelligence and the Internet of Things have enhanced the processes of numerous sectors. On the basis of different world statistics, the count of devices linked to IoT networks is quickly growing.

Through the usage of SCADA arrangements, the IoT is altering manufacturing facilities by joining a huge network of smart systems. IoT and AI-based arrangements allow industries to control and screen their developments and applications, precisely forecast machine failure, and attain quicker response times, thus growing effectiveness and reducing operational prices.

Furthermore, by utilizing IoT and AI, information is gathered, analyzed, and utilized for rising predictive models, which can help in making work well-organized and lead to augmented incomes for a company. In order to modernize plant processes, IoT and AI-based SCADA platforms streamline data transmission and study.

The surge in the rise of Industry 4.0 for both process industries and manufacturing industries quickens industry development. They utilize such facilities as part of their digitalization strategies. 

Because of their high level of technology adoption, industries are witnessing a high requirement to update the present SCADA system. Therefore, the need for these systems has been growing, mainly because of the digitization of manufacturing processes via the usage of sensors and data devices.

In the coming few years, the hardware category is projected to advance at the highest development rate, of approximately 7.8%. This can be credited to the high requirement for components such as RTU, HMI, and PLC in industrial processes and mechanization solutions to attain the targets of scalability, efficiency, and growth in the manufacturing sector.

Furthermore, progressive hardware advances the performance of systems, accountable for process mechanization, and delivers valued data. Therefore, the industry’s key players employed technologies for the growth of HMI and progressive PLCs, which can work with diverse SCADA solutions.

In recent years, North America held the major revenue share in the worldwide SCADA market. This is mainly because of the steady energy management of SCADA, huge expenditure on technologies, the increasing industrial sector, and the rising acceptance of automation technology.

Hence, the high acceptance of Industry 4.0 solutions utilizing SCADA devices, the rising usage of software platforms including artificial intelligence and the Internet of Things, and the growing requirement for industrial mobility solutions for better procedure management are the major factors propelling the SCADA market. 

Read More

Skin Booster Industry was Led by North American Region

The skin booster market will grow at a rate of 10.5% in the near future, to touch a value of USD 2,304 million by 2030.

To learn more about this report: https://bit.ly/42C8Fwz

The aging population is powering the requirement for medical aesthetics. The fibrous tissues loss and reduction of the vascular and glandular network in the skin signify aging. This brings about dryness, wrinkles, pigmentary alteration, and sagging. To overcome these issues, facial injectables are used, to revitalize and skin tightening.

As per UN-DESA, 771 million people are 65 years and above globally, having grown by over 200% from 258 million in 1980. The older populace will further reach over 990 million by 2030 and over 1.5 billion by 2050.

One of the key market drivers is the increasing predisposition of people for an enhanced appearance, for which they spend on appealing medical procedures. Therefore, advanced products are introduced, offering a higher accuracy and satisfaction of the customers. 

North America dominated the skin booster market, with around 40%, share, stated by P&S Intelligence in one of its market reports. 

This has mainly to do with the changes the perception of the consumers of the affiliation between beauty and wellbeing and the increasing prevalence of age-related skin changes. Brown rough patches, sagging skin and further blemishes are common in elderly folks. These skin issues affect up to 50 million in the U.S. on an annual basis.

The increasing elderly population, and increasing consciousness pertaining to appearance in the people around the world affects the demand for skin boosters rather positively, and it will continue to grow in the years to come.

Read More

U.S. and European Union Osteoporosis Drugs Industry Dominated by Bisphosphonates

The U.S. osteoporosis drugs market will reach USD 9,105.2 million by 2030, growing at a CAGR of 4.90%. Similarly, the EU osteoporosis drugs market revenue will be USD 4,265.4 million by the end of this decade, with a 4.65% CAGR, as stated by P&S Intelligence.

To learn more about this report: https://bit.ly/3M6v0eG

The growth is attributed to the growing incidence rate of osteoporosis, the mounting geriatric population, the surging obesity cases, the expanding occurrence of lifestyle- diseases, and the escalating healthcare expenditure in the U.S. and the EU.

On the basis of type, the bisphosphonates category had the largest revenue share, and it will maintain its ascendency in the years to come. This is because bisphosphonates have proved efficiency to minimalize fracture risk at the spine, hip and other non-vertebral skeletal sites, surge the survival rate, and decrease the considerable risk of morbidity.

Furthermore, the increasing count of women in the post-menopausal stage and an increase in the occurrence of bone diseases will further contribute to the requirement for these kinds of drugs.

The U.S. osteoporosis drugs market has a higher share of revenue and it will maintain its dominance in the future, and the EU osteoporosis drugs market will grow at a significant rate as stated by P&S Intelligence. 

This is as a result of the high incidence rate of bone-related ailments and osteoporosis-related fractures, the increasing count of clinics and hospitals, the increasing government investment for emerging cutting-edge healthcare infra, and the growing number of consciousness programs.

It is because of the increasing prevalence of osteoporosis, the demand for osteoporosis drugs will continue to increase in the U.S. and EU.

Read More

Product Lifecycle Management Market Is Dominated by Cloud Category

 As per a report by a market research institution, P&S Intelligence the product lifecycle management market was valued at USD 31,655 million in 2022, and it is expected to reach a value of USD 59,466 million, growing at a rate of 8.20%, by 2030. 

The growth in the industry is driven by the growing need for product design & innovation platforms, advancements in technology in additive manufacturing and augmented reality, and the increasing need for product smart management at manufacturing sites.  

Moreover, the COVID-19 pandemic had a positive impact on the growth of the product lifecycle management industry. This is ascribed to the significant increase in the implementation of cloud-based technology to ensure the continuity of business in the remote working model.

 

Additionally, the growing demand for smart and scalability information technology applications in various sectors, for example, electronics and automotive, will boost lifecycle management-based service and solution demand. 

 

The implementation of machine learning with product lifecycle management software provides the consumer with better-insightful knowledge from the data collected over years in a specific product.

 

In 2022, a significant share of the product lifecycle management industry was held by the software category. This is because management software offers organizations to manage the large information generated over the product lifecycle in a cost-effective and well-organized method. 

 

In 2022, the cloud category accounted for the larger product lifecycle management market share, of 72%. This is because cloud-based product lifecycle management allows consumers to access the lifecycle management data of products securely from any place, on any electronic device, and at any time. 

 

As a result of the benefits offered by cloud deployment such as flexibility, control, scalability, and security, it has become the ideal deployment mode for lifecycle management software. Cloud deployment mode also benefits in eliminating the main challenges of updating, customization, and execution.

 

In 2022, North America accounted for the largest product lifecycle management industry share, at 37%. This is because of the heavy investments and high adoption rates for new technologies in the U.S. and Canada. 

 

Furthermore, the strong economic position of the region supports businesses in investing in IoT, augmented reality, additive manufacturing, and enhance telecommunication technologies, for effective operations of business. 

 

Additionally, APAC is likely to witness significant growth over this decade, of approximately 9%, because of the extensive digitization of the processes in various industries, mainly in China and India. 

 

Hence, with the increasing requirement for smart management of products in additive manufacturing & augmented reality and the rising need for product design and innovation platforms, the product lifecycle management industry will continue its growth in the years to come.  

Read More